Asynt Launches Baffled Lab Reactor System
For a wide range of exothermic and large-scale reactions, Asynt’s ReactoMate Baffled Controlled Lab Reactor system has been shown to improve reproducibility of results, increase selectivity and reduce potentially unwanted side reactions as a result of its ability to provide fast mixing and dispersion.
By using specially designed PTFE baffle blades together with a PTFE turbine stirrer, Asynt is now able to offer scientists a new version of their 5000 mL ReactoMate Controlled Lab Reactor system, which is built to mix reactions more quickly and effectively. Most reaction vessels used by research chemists employ simple anchor or turbine stirring devices, both of which move liquid very well but usually this is in a circular direction with a vortex created in the centre. Despite this mixing looking dramatic the time for reactants to mix/disperse homogeneously with anchor or turbine stirrers is relatively slow.
This may not be an issue when the reaction under study is slow and non-exothermic however exothermic reactions such as hydrogenation, nitration, polymerisation, acid / base neutralisation and catalysis, especially those that require efficient cooling, can be seriously affected by slow dispersion during reagent addition. Similarly many reactions that work well in a lab flask often, when scaled up above 1000 mL, can also suffer seriously from this dispersion issue.
In addition to the new 5000 mL system, Asynt offers a special reactor lid, baffles and stirrer for customers to upgrade their existing suitable reaction vessels. Other size ReactoMate Baffled Controlled Lab Reactor systems are available as custom orders.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance